Genpharmasec Limited (BOM:531592)
India flag India · Delayed Price · Currency is INR
1.080
0.00 (0.00%)
At close: Nov 17, 2026

Genpharmasec Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
54.25100.7452.71188.3219.9316.07
Short-Term Investments
---16.849.5424.51
Trading Asset Securities
---12.67.0918.83
Cash & Short-Term Investments
54.25100.7452.71217.7636.5659.41
Cash Growth
7.67%91.11%-75.79%495.68%-38.47%-58.52%
Accounts Receivable
273.14296.08135.969157.0964.48
Other Receivables
-6.180.094.110.082.64
Receivables
273.2302.32136.0595.1861.9873.92
Inventory
135.45138.7573.0575.8289.7780.21
Prepaid Expenses
-1.680.180.180.210.16
Other Current Assets
256.87261.762.2320.810.771.75
Total Current Assets
719.77805.25264.22409.74189.29215.44
Property, Plant & Equipment
159.84231.2375.838.3911.04
Long-Term Investments
71.9420.83216.79176.4--
Goodwill
181.18181.18----
Other Intangible Assets
0.020.03----
Long-Term Deferred Tax Assets
1.6725.164.644.268.460.03
Long-Term Deferred Charges
-0.380.49---
Other Long-Term Assets
167.5447.595.650--
Total Assets
1,3451,382798.92711.26198.75216.5

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
171.61315.8782.5923.7913.762.21
Accrued Expenses
-29.361.391.760.210.11
Short-Term Debt
----6.01-
Current Portion of Long-Term Debt
159.5190.05----
Current Portion of Leases
2.526.025.18---
Current Income Taxes Payable
10.749.125.64---
Current Unearned Revenue
-14.83----
Other Current Liabilities
257.225.043.561.470.720.49
Total Current Liabilities
601.6470.2998.3627.0220.6462.81
Long-Term Debt
70.16239.7231.4732.124.81-
Long-Term Leases
6.4813.6816.26.78--
Pension & Post-Retirement Benefits
-0.630.1---
Other Long-Term Liabilities
1.830.76-0--0
Total Liabilities
680.06725.09146.1365.9145.4562.81

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
553.72553.72553.72553.72276.86276.86
Additional Paid-In Capital
-207.64207.64207.65--
Retained Earnings
--14.93-30.96-46.82-45.66-48.69
Comprehensive Income & Other
123.88-83.79-78.77-70.59-77.89-74.47
Total Common Equity
677.6662.65651.63643.95153.3153.7
Minority Interest
-12.76-6.21.171.4--
Shareholders' Equity
664.84656.45652.8645.35153.3153.7
Total Liabilities & Equity
1,3451,382798.92711.26198.75216.5

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
238.67349.4752.8538.8930.82-
Net Cash (Debt)
-184.42-248.73-0.13178.875.7459.41
Net Cash Growth
---3018.39%-90.34%-58.52%
Net Cash Per Share
-0.16-0.45-0.000.580.020.21
Filing Date Shares Outstanding
1,252553.72553.72533.72276.86276.86
Total Common Shares Outstanding
1,252553.72553.72533.72276.86276.86
Working Capital
118.17334.96165.86382.72168.66152.63
Book Value Per Share
0.541.201.181.210.550.56
Tangible Book Value
496.41481.43651.63643.95153.3153.7
Tangible Book Value Per Share
0.400.871.181.210.550.56
Buildings
-13.12-0.690.690.69
Machinery
-254.3759.591.020.840.68